Cogent Biosciences
COGT
#6495
Rank
ยฃ0.42 B
Marketcap
ยฃ3.70
Share price
-10.51%
Change (1 day)
-32.26%
Change (1 year)

Cogent Biosciences (COGT) - Cash on Hand

Cash on Hand as of December 2024 : ยฃ0.22 Billion

According to Cogent Biosciences's latest financial reports the company has ยฃ0.22 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cogent Biosciences - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.22 B9.69%
2023-12-31ยฃ0.20 B-2.68%
2022-12-31ยฃ0.21 B31.68%
2021-12-31ยฃ0.16 B-8.4%
2020-12-31ยฃ0.17 B522.58%
2019-12-31ยฃ28.53 M-53.91%
2018-12-31ยฃ61.91 M104.29%
2017-12-31ยฃ30.3 M-45.41%
2016-12-31ยฃ55.52 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ12.7 M-94.29%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.33 B 50.46%๐Ÿ‡บ๐Ÿ‡ธ USA